請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42914
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 于明暉(Ming-Whei Yu) | |
dc.contributor.author | Shih-Yun Chou | en |
dc.contributor.author | 周世韻 | zh_TW |
dc.date.accessioned | 2021-06-15T01:28:39Z | - |
dc.date.available | 2019-07-31 | |
dc.date.copyright | 2009-09-16 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-22 | |
dc.identifier.citation | 1. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22(33):5093-107.
2. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000;15 Suppl:E3-6. 3. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61(10):1942-56. 4. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51(20):5621-5. 5. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int J Cancer 1994;56(5):619-21. 6. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993;262(5132):369-70. 7. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337(24):1733-45. 8. Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin J. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology 1981;1(5):386-91. 9. Tang B, Kruger WD, Chen G, Shen F, Lin WY, Mboup S, et al. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol 2004;72(1):35-40. 10. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97(4):265-72. 11. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295(1):65-73. 12. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006;101(8):1797-803. 13. Wu CF, Yu MW, Lin CL, Liu CJ, Shih WL, Tsai KS, et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008;29(1):106-12. 14. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5(3):215-29. 15. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007;27(2):152-60. 16. Tan AT, Koh S, Goh V, Bertoletti A. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. J Gastroenterol Hepatol 2008;23(6):833-43. 17. Frodsham AJ. Host genetics and the outcome of hepatitis B viral infection. Transpl Immunol 2005;14(3-4):183-6. 18. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994;344(8931):1194-5. 19. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995;332(16):1065-9. 20. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 1997;26(3):503-7. 21. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007;13(12):1770-87. 22. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet 2004;5(12):889-99. 23. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007;25(6):563-7. 24. Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997;100(9):2376-85. 25. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77(22):12083-7. 26. Isaguliants MG, Ozeretskovskaia NN. [Role of a host in spontaneous recovery from viral hepatitis C: genetic predetermined factors]. Vopr Virusol 2008;53(6):40-5. 27. McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, et al. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007;117(10):3042-8. 28. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A 2001;98(9):5140-5. 29. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10(3):282-9. 30. Nolan D, Gaudieri S, John M, Mallal S. Impact of host genetics on HIV disease progression and treatment: new conflicts on an ancient battleground. AIDS 2004;18(9):1231-40. 31. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006;203(5):1357-69. 32. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317(5840):944-7. 33. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 2008;205(5):1009-17. 34. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, Tsai KS, et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 2008;26(34):5576-82. 35. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004;41(4):659-66. 36. Liu K, Muse SV. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005;21(9):2128-9. 37. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62(5):1198-211. 38. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000;66(1):279-92. 39. Sobel E, Papp JC, Lange K. Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 2002;70(2):496-508. 40. Abecasis GR, Cookson WO. GOLD--graphical overview of linkage disequilibrium. Bioinformatics 2000;16(2):182-3. 41. McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet 2007;39(7 Suppl):S37-42. 42. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007;315(5813):848-53. 43. Ionita-Laza I, Rogers AJ, Lange C, Raby BA, Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009;93(1):22-6. 44. Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 2003;37(6):1309-19. 45. Marinos G, Torre F, Gunther S, Thomas MG, Will H, Williams R, et al. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 1996;111(1):183-92. 46. Chen WN, Oon CJ. Mutations and deletions in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers. Eur J Clin Invest 2000;30(9):787-92. 47. Li KS, Yamashiro T, Sumie A, Terao H, Mifune K, Nishizono A. Hepatitis B virus harboring nucleotide deletions in the core promoter region and genotype B correlate with low viral replication activity in anti-HBe positive carriers. J Clin Virol 2001;23(1-2):97-106. 48. Peng XM, Huang GM, Li JG, Huang YS, Mei YY, Gao ZL. High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World J Gastroenterol 2005;11(20):3131-4. 49. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347(3):168-74. 50. Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002;3(8):617-28. 51. Lavori PW, Krause-Steinrauf H, Brophy M, Buxbaum J, Cockroft J, Cox DR, et al. Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. Control Clin Trials 2002;23(3):222-39. 52. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160(4):636-45. 53. Hasler G, Drevets WC, Gould TD, Gottesman, II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006;60(2):93-105. 54. Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol Med 2007;37(2):163-80. 55. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009;41(5):591-5. 56. Sjolund K, Sanden G, Hakanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983;85(5):1120-30. 57. Yamada J, Rodrigues MA, Kitamura N, Pai VD, Yamashita T, Motizuki T, et al. Motilin-immunoreactive cells in the duodenum, pyloric stomach and pancreas of caimans (Caiman latirostris and Caiman crocodilus, alligatorinae): a further comparison using region-specific motilin antisera. Arch Histol Cytol 1991;54(3):359-64. 58. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong SS, et al. Receptor for motilin identified in the human gastrointestinal system. Science 1999;284(5423):2184-8. 59. Rajeswari MR, Jain A. High-mobility-group chromosomal proteins, HMGA1 as potential tumour markers. Current Science 2002;82(7):838-844. 60. Hoyos JM, Fedele M, Battista S, Pentimalli F, Kruhoffer M, Arra C, et al. Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: Tissue specificity of the HMGA1-dependent gene regulation. Cancer Research 2004;64(16):5728-5735. 61. Chang ZG, Yang LY, Wang W, Peng JX, Huang GW, Tao YM, et al. Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker. Dig Dis Sci 2005;50(10):1764-70. 62. Chau KY, Keane-Myers AM, Fedele M, Ikeda Y, Creusot RJ, Menozzi L, et al. IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1. International Immunology 2005;17(3):297-306. 63. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 2005;11(23):8295-303. 64. Takeshita E, Matsuura B, Dong M, Miller LJ, Matsui H, Onji M. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 2006;41(3):223-30. 65. Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006;439(7078):851-5. 66. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007;80(6):1037-54. 67. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007;39(6):721-3. 68. Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, et al. Mapping and sequencing of structural variation from eight human genomes. Nature 2008;453(7191):56-64. 69. Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, et al. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res 2009;69(6):2176-9. 70. Veenstra-Vanderweele J, Christian SL, Cook EH, Jr. Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 2004;5:379-405. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42914 | - |
dc.description.abstract | 背景:血液中B型肝炎病毒DNA濃度稱為B型肝炎病毒量,不僅可以反應病毒在體內的複製活性,也是肝細胞癌的重要危險因子。此外,染色體6p21.3區域除包含人類白血球抗原(HLA)基因外,亦有許多和病毒感染有關的免疫基因;本研究目的為在6p21.3位置尋找與病毒量控制相關之數量性狀基因座(QTL)。材料與方法:本研究第一階段採家族相關性分析,藉由收集HCC指標個案之親屬,共有309個家族及846位B肝帶原者(474位男性及372位女性),以傳遞不平衡原理,採用QTDT分析6p21.3區域上14個微衛星標記(microsatellite marker)。根據QTDT結果,我們在長期追蹤樣本中選取115名HCC病例及345名年齡配對之對照,採重疊病例對照研究法分析此區域之DNA拷貝數的變異(copy number polymorphism)對HBV病毒量控制及HCC發生影響。結果:4個DNA標記(D6S273, D6S1629, D6S1202i and D6S1611i)在QTDT分析結果中和病毒量呈現顯著相關,最顯著的結果出現在D6S1629(P=0.0006; permutated P=0.0010),此標記在多重比較校正後依然呈現顯著結果(p=0.05)。下一階段CNP分析也有相同結果,分析之CNP距離D6S1629約130kb,在家族研究及重疊病例對照研究中均和病毒量呈現顯著負相關。此外,此CNP也和肝硬化(1 vs 2 copies: 相對危險性=3.05; 95%信賴區間=1.46-6.37)及肝癌(1 vs 2 copies: 相對危險性=3.22; 95%信賴區間=1.63-6.35)發生有顯著危險性。結論:此一包含CNP之HLA區域可能和宿主HBV控制及HCC發展有關,CNP相關功能性分析值得進一步研究。 | zh_TW |
dc.description.abstract | Background: Hepatitis B virus (HBV) load measured in terms of HBV DNA levels in blood is an index of viral replication activity and an important risk factor for hepatocellular carcinoma (HCC). Many genes in human leukocyte antigen (HLA) region encode proteins critical in activating immune response to viral infection. This study aimed to localize quantitative trait loci for host control of HBV viral load in this region. Materials and Methods: The family sample consisted of 846 HBsAg-positive subjects (474 men and 372 women) from 309 different families; each was ascertained through a single HBsAg-positive index patient with HCC. We performed family-based association analysis by using QTDT with a high-density map of genetic markers across a 7.2-Mb region at 6p21.3. To further determine whether HLA alleles may affect HBV viremia and thus the development of HCC, we analyzed a copy number polymorphism (CNP) located near an implicated region identified by QTDT in a case-control sample containing 115 HCC cases and 345 age-matched controls nested within a longitudinal cohort study. Result: Significant associations with HBV viremia were found with QTDT for 4 genetic markers (D6S273, D6S1629, D6S1202i and D6S1611i), with marker D6S1629 showing maximal association (nominal P=0.0006; permutated P=0.0010). The association with marker D6S1629 remained significant even after the most conservative correction for multiple tests by Bonferroni procedure (p=0.05). We consistently observed an inverse association between the number of a CNP, located ~130 kb apart from marker D6S1629, and reduced viral load in both family and nested case-control studies. In addition, copy loss was observed to be a risk factor for the development of liver cirrhosis (one vs two copies: adjusted odds ratio=3.05; 95% confidence interval=1.46-6.37) and HCC (one vs two copies: adjusted odds ratio=3.22; 95% confidence interval=1.63-6.35). Conclusions: The data indicate that a CNV in HLA region may be associated with high viremia of HBV and predisposition to HCC. Further functional studies focusing on the investigation of the nature of this CNV that is underling our observed association are warranted. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:28:39Z (GMT). No. of bitstreams: 1 ntu-98-R96842015-1.pdf: 449077 bytes, checksum: 4c88873998013b3a452c0f6983227c5d (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 中文摘要 i
Abstract ii Background 1 Material and Method 6 Result 11 Discussion 15 Reference 20 | |
dc.language.iso | en | |
dc.title | 搜尋HLA區域肝細胞癌家族控制B型肝炎病毒複製活性之數量性狀基因座 | zh_TW |
dc.title | Searching for a Quantitative Trait Locus in HLA Region for Host Control of HBV Replication in Families with Hepatocellular Carcinoma | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 郭育良,張久瑗,莊雅惠 | |
dc.subject.keyword | B型肝炎病毒,病毒量,HLA,家族相關性分析,傳遞不平衡檢定,拷貝數變異,重疊病例對照研究, | zh_TW |
dc.subject.keyword | Hepatitis B virus,viral load,HLA,family-based association study,QTDT,CNV,nested case-control study, | en |
dc.relation.page | 36 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-22 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 438.55 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。